e-learning
resources
Munich 2006
Sunday 03.09.2006
COPD – inflammation/miscellaneous
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy
L. S. Corkovic, D. D. Begovic, S. S. Jelic, T. A. Milosevic, V. R. Miloskovic, M. D. Obradovic, R. Garovic, S. Ignjatovic (Belgrade, Kragujevac, Mladenovac, Serbia And Montenegro)
Source:
Annual Congress 2006 - COPD – inflammation/miscellaneous
Session:
COPD – inflammation/miscellaneous
Session type:
E-Posters in free access
Number:
333
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. S. Corkovic, D. D. Begovic, S. S. Jelic, T. A. Milosevic, V. R. Miloskovic, M. D. Obradovic, R. Garovic, S. Ignjatovic (Belgrade, Kragujevac, Mladenovac, Serbia And Montenegro). Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy. Eur Respir J 2006; 28: Suppl. 50, 333
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Serum vitamin D level is associated with emphysema progression in male patients with COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Serum ascorbic acid concentration in patients with acute pneumonia and in COPD patients with and without respiratory failure
Source: Eur Respir J 2004; 24: Suppl. 48, 92s
Year: 2004
Does vitamin D deficiency worsen the hospital outcome in patients with acute exacerbation COPD?
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Plasma vitamin D concentration and clinical characteristics in clinically stable patients with moderate COPD
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011
The relationship between respiratory muscle dysfunction and serum vitamin D level in COPD patients
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Serum magnesium levels in acute exacerbation of COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007
Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
Relationship between vitamin A and inflammation in the sputum and serum of smokers and COPD patients
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD
Source: Eur Respir J 2015; 45: 76-86
Year: 2015
Profile of serum vitamin D levels in stable COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Risk of bacterial infection in COPD patients with Vitamin D defficiency
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
LSC Abstract – Effects of vitamin D supplementation on perioperative markers of inflammation in patients at risk of acute respiratory distress syndrome (ARDS)
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016
Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Vitamin D status in COPD patients admitted for exacerbation
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005
Vitamin C level in the serum of smokers and non-smokers with COPD in stable state and during exacerbation
Source: Eur Respir J 2007; 30: Suppl. 51, 556s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept